Document is current
Any future updates will be listed below
-
Authors
Khubchandani, Jasmine A.
Suttiratana, Sakinah C.
Washington, Rosetta
White-Bracey, Dawn
KC, Madhav
Silber, Andrea
Fayanju, Oluwadamilola M.
Butler, Paris D.
Menon, Alka
Greenup, Rachel A.
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (TL1 TR001864)
National Cancer Institute (1R01CA256877-01A1, P30CA016359)
National Institutes of Health (2P30CA016520, 7K08CA241390-03, P50CA24469)
- License Information
-
More Information
Article History
Received: 7 October 2024
Accepted: 7 October 2024
First Online: 18 October 2024
Disclosure
: This manuscript was made possible by the Yale National Clinician Scholars Program and by CTSA Grant Number TL1 TR001864 from the National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH. This manuscript was also made possible from support provided by the VA Office of Academic Affiliations through the VA/National Clinician Scholars Program and Yale University. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. This investigation was supported by NIH Research Grant P30CA016359 from the National Cancer Institute through the Yale Cancer Center. Dr. Rachel Greenup is supported by funding from the National Cancer Institute Grant 1R01CA256877-01A1. Dr. Fayanju is supported by the National Institutes of Health (NIH) under Award Numbers 7K08CA241390-03 (PI: Fayanju), P50CA244690 (PI: Bekelman), and 2P30CA016520 (PI: Vonderheide); the Breast Cancer Research Foundation, and philanthropic funds from the Haas family. She also reports research support unrelated to this work from Gilead Sciences, Inc. Dr. Andrea Silber is a consultant for Astra Zeneca.
